United States · FDA National Drug Code directory
INVOKAMET XR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50458-940_95b8c81c-dfe3-4dd4-be06-8dd1d935f07e
- Product NDC
- 50458-940
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- canagliflozin and metformin hydrochloride
- Labeler
- Janssen Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20160920
- Source listing expiry
- 20271231
Source-listed ingredients
- CANAGLIFLOZIN — 50 mg/1
- METFORMIN HYDROCHLORIDE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50458-940-01) · 50458-940-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →